From the Business Ethics Blog: Personal Genomics: the Ethics of Shared Uncertainty
Yesterday afternoon I gave a talk there, called “Direct-to-Consumer Genetic Testing: Consumer Empowerment or High-Tech Fortune-Telling?”
I didn’t talk about genetic testing in general, but rather specifically about at-home genetic tests (a.k.a. “personal genomics” services) sold by companies like 23andMe, Navigenics, and deCode.
The scientific consensus (among academic and clinical geneticists, anyway) seems to be that such tests aren’t worth much.